High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis - Takeaways - MDSpire

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis

  • By

  • Kristoffer Grundtvig Skaarup

  • Mats C. H. Lassen

  • Kaveh Hosseini

  • Niklas Dyrby Johansen

  • Matthew M. Loiacono

  • Rebecca C. Harris

  • Sandrine I. Samson

  • Arto A. Palmu

  • Kevin McConeghy

  • Stefan Gravenstein

  • Orly Vardeny

  • Brian Claggett

  • Scott D. Solomon

  • Federico Martinón-Torres

  • Tor Biering-Sørensen

  • May 26, 2026

  • 0 min

Share

  • 1

    High-dose inactivated influenza vaccine (HD-IIV) contains 60 µg hemagglutinin antigen per strain, four times that of standard-dose inactivated influenza vaccine (SD-IIV).

  • 2

    HD-IIV has shown a relative vaccine efficacy of 24.2% compared to SD-IIV in preventing laboratory-confirmed influenza in adults aged 65 and older.

  • 3

    The FLUNITY-HD study demonstrated that HD-IIV provides superior protection against hospitalizations for pneumonia, cardiorespiratory disease, and all causes compared to SD-IIV.

  • 4

    A meta-analysis including 105,685 participants indicated that HD-IIV is associated with reduced hospitalizations for pneumonia or influenza compared to SD-IIV.

  • 5

    The meta-analysis aimed to summarize findings from randomized trials comparing HD-IIV and SD-IIV for preventing severe clinical outcomes in older adults.

Original Source(s)

Related Content